| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2003 | US20030040023 Isolation of neural stem cells using gangliosides and other surface markers |
| 02/27/2003 | US20030040014 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040007 Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 02/27/2003 | US20030040003 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039994 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039993 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/27/2003 | US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039953 Method for selecting spermatozoon |
| 02/27/2003 | US20030039952 Method of preparing and thawing cryopreserved cells |
| 02/27/2003 | US20030039705 Triterpene compositions and methods for use thereof |
| 02/27/2003 | US20030039678 Xenograft bone matrix for orthopedic applications |
| 02/27/2003 | US20030039666 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039656 Modified reoviral therapy |
| 02/27/2003 | US20030039653 Identifying a mammal with, or at risk of developing, cancer; cells of the cancer are identified as expressing B7-H1 molecules on their surfaces, and administering an agent that interferes with interaction between B7-H1 and t-cells |
| 02/27/2003 | US20030039650 Adminstering t-cells that have been isolated and expanded ex vivo from a patient with an immune imbalance back into the patient |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells |
| 02/27/2003 | US20030039643 Investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-N- acetylglucosaminidase deficiency |
| 02/27/2003 | US20030039642 Embryonic stem cells, clinical applications and methods for expanding in vitro |
| 02/27/2003 | US20030039641 Cells expressing anti-fc receptor binding components |
| 02/27/2003 | US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus |
| 02/27/2003 | US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 02/27/2003 | US20030039638 Administering to a donor a pharmaceutical composition containing carbon monoxide, obtaining an organ, tissue or cell and transplanting to a recipient |
| 02/27/2003 | US20030039636 Novel self-inactivating (SIN) lentiviral vectors |
| 02/27/2003 | US20030039634 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 02/27/2003 | US20030039629 Espression enhancer for protein synthesis inhibitory genes |
| 02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | CA2497343A1 Systems and methods for screening pharmaceutical chemicals |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457850A1 Novel amylases and uses thereof |
| 02/27/2003 | CA2457799A1 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457461A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 02/27/2003 | CA2457298A1 Novel human collagen proteins and polynucleotides encoding the same |
| 02/27/2003 | CA2457236A1 Premeabilisation of cells |
| 02/27/2003 | CA2457226A1 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 02/27/2003 | CA2457163A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | CA2457143A1 In situ immunization |
| 02/27/2003 | CA2457065A1 Periostin-based diagnostic assays |
| 02/27/2003 | CA2457060A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
| 02/27/2003 | CA2456716A1 Tissue implants and methods for making and using same |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2455827A1 Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2452160A1 Generation of multipotent central nervous system stem cells |
| 02/27/2003 | CA2451998A1 Anti-a.beta. antibodies |
| 02/26/2003 | WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | EP1285967A2 Human retroviral packaging cell line |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285962A1 NADH oxidase from Lactobacillus |
| 02/26/2003 | EP1285961A1 Method of forming vertebrate pancreas in vitro |
| 02/26/2003 | EP1285930A2 Human antibodies that bind human TNFalpha |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285081A2 Improved methods of transfection |
| 02/26/2003 | EP1285079A2 Modified bovine adenovirus having altered tropism |
| 02/26/2003 | EP1285078A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 02/26/2003 | EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285067A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 02/26/2003 | EP1285066A1 F-box containing protein |
| 02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
| 02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
| 02/26/2003 | EP1285059A2 Adjuvant preparation for the induction of specific immunity |
| 02/26/2003 | EP1285058A2 Fertilization of aged oocytes |
| 02/26/2003 | EP1285057A1 Isolation of mesenchymal stem cells and use thereof |
| 02/26/2003 | EP1284997A2 Therapeutic compounds for ovarian cancer |
| 02/26/2003 | EP1284996A2 Therapeutic anti-melanoma compounds |
| 02/26/2003 | EP1284995A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 02/26/2003 | EP1284756A1 Shape memory thermoplastics and polymer networks for tissue engineering |
| 02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
| 02/26/2003 | EP1284747A2 Compositions and methods for achieving immune suppression |
| 02/26/2003 | EP1284743A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 02/26/2003 | EP1284597A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides |
| 02/26/2003 | EP1284596A2 APPARATUS AND PROCESS FOR i IN SITU /i MANUFACTURE OF ESSENCE FROM LIVING, UNCUT PLANTS |
| 02/26/2003 | EP1240314A4 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 02/26/2003 | EP1096849B8 A process for production and subsequent (ex vitro) sowing and propagation of pre-germinated plant somatic embryos |
| 02/26/2003 | EP0946138B1 Use of a potentilla erecta extract in the cosmetic and pharmaceutical field |
| 02/26/2003 | EP0944396B1 Compositions and methods for enhancing intestinal function |
| 02/26/2003 | EP0877941B1 Method for bulk enrichment of a population or subpopulation of cells |
| 02/26/2003 | EP0822986B1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/26/2003 | EP0770137B1 Improvements in production of proteins in host cells |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0691806B1 Method of somatic hybridization of algal species |
| 02/26/2003 | EP0672140B1 TRANSFECTED CELL LINE EXPRESSING cDNAs ENCODING HUMAN NMDA-R2A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT |
| 02/26/2003 | CN1399718A Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
| 02/26/2003 | CN1399681A Methods for enhancing the production of cytokines in cell culture |